Company Amniotics AB

Equities

AMNI

SE0015961016

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 28/06/2024 pm IST			5-day change	1st Jan Change
0.0055 ^SEK	-8.33%		+10.00%	-38.89%

20/05	Magle Chemoswed Holding AB (OM:MAGLE) cancelled the acquisition of 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other.	CI
22/03	Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.	CI

Amniotics AB (publ) is a Sweden-based biotech company that develops cell therapy drugs based on mesenchymal stem cells from amniotic fluid in its in-house GMP licensed facility. Amniotics' own marker technology is used to identify and select stem cells for different tissue types; Lung (PulmoStem), Brain (CogniStem), Kidney (NephroStem), Skin (CutiStem). It allows for selecting the type of cell to be used for specific tissue. The company has developed a process - patented in all steps - which includes collection of amniotic fluid, with a medical device developed by Amniotics, followed by sorting and propagation of stem cells and packaging of product in ampoules in its own GMP facility. Amniotics is a technology and service provider to Universities, Hospitals, and the Biopharmaceutical industry.

Number of employees: 6

Managers	Title	Age	Since
Marcus Kåre Torleif Larsson FOU	Founder	51	01/15/01
Gerton Jönsson DFI	Director of Finance/CFO	53	02/23/02
Matilda Hugerth CTO	Chief Tech/Sci/R&D Officer	49	-
Jan Talts COO	Chief Operating Officer	59	01/17/01

Members of the board	Title	Age	Since
Peter Buhl Jensen CHM	Chairman	69	15/21/15
Sven Fredrik Tiberg BRD	Director/Board Member	61	15/21/15
Ingrid Atteryd Heiman BRD	Director/Board Member	66	15/21/15
Marcus Kåre Torleif Larsson FOU	Founder	51	01/15/01
Christopher Bravery BRD	Director/Board Member	57	15/21/15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	2,710,547,775	1,370,681,971 ( 50.57 %)	0	50.57 %

Amniotics AB

Scheelevägen 2

223 63, Lund

+46 0 72 32 78 520

http://www.amniotics.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
AMNIOTICS AB	-38.89%	1.42M
MODERNA, INC.	+19.41%	45.51B
LONZA GROUP AG	+38.65%	38.13B
IQVIA HOLDINGS INC.	-8.62%	38.52B
ALNYLAM PHARMACEUTICALS, INC.	+26.95%	30.74B
CELLTRION, INC.	-13.50%	26.03B
ICON PUBLIC LIMITED COMPANY	+10.74%	25.92B
UNITED THERAPEUTICS CORPORATION	+44.87%	14.13B
MEDPACE HOLDINGS, INC.	+34.36%	12.73B
BIO-TECHNE CORPORATION	-7.14%	11.29B

Other Biotechnology & Medical Research